Skip to main content
assisted 500+ manufacturing compliance files | 28 states covered

GMP Certification and revised Schedule M readiness

Get expert assistance for Good Manufacturing Practices compliance: a gap assessment against the revised Schedule M, the quality system and Site Master File, and the WHO-GMP and COPP applications on the ONDLS portal. From a ₹24,999 professional fee.

  • Gap assessment against the revised Schedule M, not the old one
  • Pharmaceutical Quality System built, not retrofitted
  • Site Master File that describes the actual facility
  • Mock inspection before the joint inspection arrives
Reviewed by Industry Experts & Startup Specialists.
Last Updated: 
FREE Consultation Get Started @ ₹299 ₹0

Get Expert Consultation

Share Your Business Requirement

Instant Response 100% Confidential Expert Advice

Encrypted in transit We do not sell your data

Compliance files
500+
States covered
28
WHO-GMP validity
3 yrs
Client rating
4.9/5

Our partners & associations

Client RatingRazorpay TrustedZoho Partner
FAQs

Frequently asked questions about GMP certification

38 questions sourced from real search queries, the revised Schedule M, CDSCO guidance and our experience having assisted 500+ manufacturing compliance files.

Key takeaway
The ProTax professional fee starts at ₹24,999, with the actual figure driven by scope: a single-product oral solid dosage unit and a sterile facility are not comparable exercises. Government fees, laboratory testing, validation studies and any facility upgrade are billed at actuals, and the physical upgrade is normally the largest line in a GMP project. Timelines run 8 to 16 weeks for documentation and 6 to 12 months where engineering work is involved.
  • Professional feeFrom ₹24,999
  • Facility upgradeAt actuals
  • Documentation route8 to 16 weeks
  • WHO-GMP validityTypically 3 years

What the GMP package includes

Cost breakdown: professional fee and pass-through charges
ComponentAmount (₹)Notes
ProTax professional fee, documentation routeFrom 24,999Gap assessment, quality system, Site Master File, application filing
Sterile or multi-block facility scopeQuoted on scopeSubstantially larger documentation and validation exercise
Government fees for WHO-GMP and COPPAt actualsPayable to the licensing authority through the ONDLS portal
Laboratory testing and stability studiesAt actualsThrough the facility laboratory or an accredited external laboratory
Validation and qualification studiesAt actualsEquipment, utilities, process and computerised system validation
Facility, HVAC and water system upgradeAt actualsEngineering work, normally the largest line in the project
ProTax professional feeFrom ₹24,999No markup on any government fee or third-party charge

What drives the cost and the timeline

Not the number of products. The gap between what the facility is and what the revised Schedule M expects, and how much of that gap is physical rather than documentary.

FactorEffectWhy
Physical upgrade neededLargest driverPremises, HVAC, water systems and equipment set a 6 to 12 month clock
Sterile or high-risk dosage formsIncreasesHeavier qualification, validation and environmental monitoring
Computerised systems in useIncreasesValidation, audit trails and user access controls all in scope
Existing quality system maturityDecreasesA functioning system needs updating rather than building
Documentation-only gapsBaselineProcedures, records and the Site Master File, on an 8 to 16 week route

Schedule M is made under the Drugs and Cosmetics Act, 1940. Applications for WHO-GMP certificates and Certificates of Pharmaceutical Product are filed on the ONDLS portal of the Central Drugs Standard Control Organisation. Confirm the current position before planning an application.

Note: Prices are ProTax professional fees for assistance; government fees, where they apply, are extra and billed at actuals.

Pricing terms

What the listed price covers, and what it does not.

  • Professional fee

    Listed amounts are ProTax professional charges for the assistance described in each plan.

  • Government fees

    Government fees, stamp duty and other statutory or third-party charges, where they apply, are additional and billed at actuals.

  • Confirmed before you pay

    The professional fee and the expected government fees for your case are confirmed before you pay.

  • Approval

    Where a government application is involved, the issuing authority decides it. ProTax prepares and files the application and cannot guarantee the outcome.

  • Timelines

    Timelines are typical estimates and depend on government portal availability and processing times.

Why ProTax

Frequently asked questions about GMP certification

38 questions sourced from real search queries, the revised Schedule M, CDSCO guidance and our experience having assisted 500+ manufacturing compliance files.

From ₹24,999 professional fee

One fee for the gap assessment and documentation build, scoped and quoted before work begins. Government fees, testing, validation studies and any facility upgrade are billed at actuals.

Documentation gaps separated from engineering

A missing procedure takes days. An HVAC upgrade takes months. We split the gap list on that line at the start so the plan reflects what is actually achievable and by when.

Data integrity taken seriously

Shared logins, unreviewed audit trails and reconstructed records are where units that passed comfortably under the old Schedule M now fail. We close those before the inspection, not after.

Mock inspection first

We walk the facility against the revised Schedule M with fresh eyes and produce the findings the inspector would, while you still have time to close them.

FAQs

Frequently asked questions about

Key takeaway
Good Manufacturing Practices are the standards a facility must meet so products are consistently produced and controlled to the quality their intended use requires. For drugs in India that is Schedule M to the Drugs and Cosmetics Rules, 1945, substantially rewritten and notified on 28 December 2023. Compliance is a licence condition. The separate WHO-GMP certificate and product-wise COPP are what exporters obtain, filed on the ONDLS portal.
  • Governing ruleSchedule M, D&C Rules 1945
  • Enforced byState authority and CDSCO
  • ApplicationsONDLS portal
  • WHO-GMP validityTypically 3 years

GMP certification is a phrase that covers two different things, and separating them is the first useful step. The first is compliance with Schedule M to the Drugs and Cosmetics Rules, 1945, which is a condition of the drug manufacturing licence and applies whether or not any certificate is ever issued. The second is the WHO-GMP certificate and the product-wise Certificate of Pharmaceutical Product, which are documents applied for and issued after inspection, and which overseas buyers and importing regulators actually ask to see. This page covers both, plus the parallel GMP regimes for Ayush products, food, cosmetics and medical devices.

The reason GMP is a live issue rather than a settled one is the revised Schedule M notified on 28 December 2023. It moves Indian requirements substantially closer to WHO-GMP and EU-GMP expectations, introducing a formal Pharmaceutical Quality System, Quality Risk Management, an annual Product Quality Review, qualification and validation discipline extending to computerised systems, and data integrity requirements aligned to ALCOA+ principles. Manufacturers above ₹250 crore turnover were given the shorter transition. Micro, small and medium manufacturers up to that turnover were given twelve months, and those who applied in the prescribed form received an extension to 31 December 2025.

That extension has expired, and no further general extension followed. The Central Drugs Standard Control Organisation has directed state drug control authorities to inspect manufacturing units against the revised requirements, and units that never applied for the extension are inspected without any grace period at all. For a manufacturer that has been treating the revision as a future project, the position in 2026 is that the inspection is the deadline. Explore all licenses and registrations.

Pharmaceutical manufacturing facility being prepared for a revised Schedule M GMP inspection Revised Schedule M

A licence condition, not a certificate to buy

No advisory firm can certify a facility. The licensing authority inspects and decides. What preparation buys you is a facility and a file that survive that inspection.

  • Schedule M compliance is required with or without a certificate
  • WHO-GMP and COPP are separate, for export
  • The MSME extension expired on 31 December 2025
FAQs

Frequently asked questions about GMP certification vs a private certificate

38 questions sourced from real search queries, the revised Schedule M, CDSCO guidance and our experience having assisted 500+ manufacturing compliance files.

Substantive requirements introduced or strengthened in the revision
RequirementWhat it means in practiceWhere units commonly fall short
Pharmaceutical Quality SystemA formal system covering responsibilities, procedures, change control, deviations, CAPA, self-inspection and management reviewProcedures exist on paper but the system is not demonstrably operating
Quality Risk ManagementDocumented assessment, control, communication and review of quality risksDecisions taken without a recorded risk rationale
Product Quality ReviewPeriodic review per product of batch data, deviations, changes, stability, complaints and recallsNever performed, or performed without conclusions
Qualification and validationPremises, utilities, equipment, processes and analytical methodsRecords that do not match the equipment installed
Computerised system validationValidation, audit trails and user access managementShared logins and audit trails never reviewed
Data integrity, ALCOA+Records attributable, legible, contemporaneous, original and accurateRecords completed after the event or reconstructed
Change controlAssessment and approval before the change is madeChange control raised after implementation
Self-inspectionPlanned internal audit with findings tracked to closurePerformed as a formality with no findings recorded

The pattern in that right-hand column is worth naming. Very few units fail a revised Schedule M inspection because the standard is unattainable. They fail because the system is real but undocumented, or documented but not demonstrably operating. An inspector cannot credit what cannot be evidenced, and the revision has narrowed the space in which a well-run but lightly documented facility could previously get by.

The second pattern is data integrity. A quality control laboratory with a shared analyst login, an instrument whose audit trail has never been reviewed, and a chromatography system where results can be reprocessed without trace is a finding under the revised requirements, regardless of whether the underlying results are sound. This is the single most common area of genuine, expensive gap for units that were entirely comfortable under the previous Schedule M.

The extension has expired

The compliance window for micro, small and medium manufacturers with turnover up to ₹250 crore, extended to 31 December 2025 for those who applied in the prescribed form, has closed and no further general extension followed. CDSCO has directed state authorities to inspect. Units that never applied for the extension have no grace period at all.

FAQs

Frequently asked questions about GMP certification

38 questions sourced from real search queries, the revised Schedule M, CDSCO guidance and our experience having assisted 500+ manufacturing compliance files.

GMP regimes in India by product type
ProductStandardAuthorityExport certificate
Drugs and pharmaceuticalsSchedule M, D&C Rules 1945State Licensing Authority with CDSCOWHO-GMP certificate and COPP
Ayurvedic, Siddha and Unani medicinesSchedule T, D&C Rules 1945State licensing authority for AyushAyush GMP and COPP where applicable
Medical devicesFifth Schedule, Medical Devices Rules, 2017CDSCO and state authoritiesISO 13485 commonly required by buyers
Food and nutraceuticalsSchedule 4, FSS Licensing Regulations, 2011FSSAIBuyer-driven; HACCP and ISO 22000 common
CosmeticsCosmetics Rules, 2020State licensing authorityISO 22716 commonly required by buyers
Veterinary productsSchedule M applied to the categoryState Licensing AuthorityWHO-GMP route where applicable

Getting this wrong is more common than it sounds, because a single group can hold licences across categories. A company making an allopathic tablet, an Ayurvedic syrup and a nutraceutical powder is subject to Schedule M, Schedule T and Schedule 4 to the FSS Licensing Regulations, 2011 respectively, in three separate licence tracks with three different inspecting authorities. Explore Ayush licensing, nutraceutical licensing and FSSAI licensing.

A private GMP certificate is not a WHO-GMP certificate

Third-party bodies issue voluntary GMP certificates against WHO GMP or similar criteria, and they carry some commercial weight with buyers. They are not issued by a licensing authority, they do not discharge the Schedule M obligation, and where an importing regulator asks for WHO-GMP they will not close the requirement. Check what the buyer actually needs before commissioning either.

FAQs

GMP certification vs a private certificate

38 questions sourced from real search queries, the revised Schedule M, CDSCO guidance and our experience having assisted 500+ manufacturing compliance files.

Documents by category of evidence
CategoryDocumentPurpose
LicenceDrug manufacturing licence with product scheduleEstablishes what may lawfully be made at the site
Site plan and approved layoutCompared against the facility on the walk
Site descriptionSite Master FileThe first document an inspector reads
Quality systemQuality manual and proceduresEvidences the Pharmaceutical Quality System
Change control, deviation and CAPA recordsShows the system operating, not just existing
Self-inspection reports with closure evidenceInternal audit discipline
Management review recordsTies quality data to management decisions
QualificationPremises, utility and equipment qualificationMust match the equipment actually installed
HVAC and water system schematics and monitoringEnvironmental and utility control evidence
ValidationProcess validation reportsDemonstrates the process is reproducible
Analytical method validationDemonstrates the test methods are fit for purpose
Computerised system validation and audit trail reviewData integrity evidence
ProductBatch manufacturing and packaging recordsContemporaneous evidence of each batch
Stability data and Product Quality ReviewOngoing evidence of continued fitness
Product summary sheets and labelsRequired for the WHO-GMP and COPP applications

Pro tip: retrievability is part of the evidence

A record that exists but takes two days to locate reads to an inspector like a record that does not exist. Before the inspection, pick ten documents at random across quality, production and the laboratory and time how long it takes to produce them. If any takes more than a few minutes, the filing system is a finding waiting to be written.

FAQs

Frequently asked questions about GMP certification

38 questions sourced from real search queries, the revised Schedule M, CDSCO guidance and our experience having assisted 500+ manufacturing compliance files.

01

Establish the applicable GMP regime

Identify whether the facility sits under Schedule M, Schedule T for Ayush, the Fifth Schedule to the Medical Devices Rules, 2017, Schedule 4 to the FSS Licensing Regulations, or the Cosmetics Rules, 2020. A group with multiple licences may sit under more than one.

02

Run the gap assessment

Assess premises, utilities, equipment, the quality system and the records against the revised requirements, and separate documentation gaps from engineering gaps because they carry entirely different timelines and costs.

03

Build the Pharmaceutical Quality System

Define responsibilities and implement change control, deviation, CAPA, self-inspection and management review, with the link from product quality data back into improvement. This is the part that cannot be created the week before an inspection.

04

Prepare the Site Master File

Document the site as it actually is: layout, products, personnel, premises, utilities, equipment, quality system, production, quality control, contract activities, distribution, complaints, recalls and self-inspection.

05

Complete qualification and validation

Qualify premises, utilities and equipment; validate processes, analytical methods and computerised systems including audit trails and user access. Reconcile every record against the equipment on the floor.

06

Establish data integrity controls

Apply ALCOA+ across paper and electronic records: unique user access, contemporaneous entry, audit trail review, controlled issue of blank forms and retention that keeps records retrievable.

07

Run the Product Quality Review

Complete the periodic review per product across batch data, out-of-specification and out-of-trend events, deviations, changes, stability, returns, complaints and recalls, ending in a stated conclusion.

08

Assemble the WHO-GMP application

Compile the manufacturing licence, Site Master File, product summary sheets, stability data, process validation reports, HVAC and water schematics, previous inspection reports, labels and artwork for the products applied for.

09

File on the ONDLS portal

Submit the WHO-GMP certificate and COPP applications electronically on the Online National Drugs Licensing System, which has been the only accepted route since 15 July 2025.

10

Mock inspect, then host the joint inspection

Run a mock inspection with fresh eyes, then host the joint inspection by the State Licensing Authority and CDSCO, and answer every observation with a dated corrective and preventive action plan supported by evidence.

Common mistake

Writing the Site Master File to describe the facility you intend to have rather than the one you have. Inspectors walk the site against that document, and every difference between the two becomes an observation, plus a credibility problem that colours the rest of the inspection. Describe what exists, and list the upgrades separately as a dated plan.

Get your facility assessed against the revised Schedule M

A professional fee from ₹24,999 for the gap assessment, quality system documentation, Site Master File and application filing. Government fees, testing and upgrades at actuals.

FAQs

Frequently asked questions about GMP certification

38 questions sourced from real search queries, the revised Schedule M, CDSCO guidance and our experience having assisted 500+ manufacturing compliance files.

ParameterWHO-GMP certificateCertificate of Pharmaceutical Product (COPP)
What it coversThe manufacturing facility, for stated productsA specific product and its regulatory status
Issued byState Licensing Authority, with CDSCO in the inspectionState Licensing Authority or CDSCO by licensing route
Based onA GMP inspection of the facilityThe facility position plus the product licence position
Typical validityThree yearsTwo years
FormatAuthority format confirming GMP complianceWHO certification scheme format
Product-specific No Yes
Filed on ONDLS Yes Yes
Who asks for itBuyers and importing regulators generallyThe importing country regulator, product by product

Both are filed on the Online National Drugs Licensing System portal, which has been the only accepted route since 15 July 2025, with physical submissions no longer taken. The application package for a WHO-GMP certificate is substantial: the manufacturing licence, the Site Master File, product summary sheets, stability data, process validation reports, HVAC and water system schematics, the previous inspection report where one exists, and the actual product labels. A joint inspection by the state authority and CDSCO then follows before the certificate issues.

The scope point matters commercially. The certificate covers the products stated in the application, so adding a product later is a fresh application for the added scope rather than an automatic extension. Exporters entering a new market are better served by working backwards from what that market's regulator requires than by obtaining a broad certificate and hoping it covers the position.

FAQs

Frequently asked questions about GMP certification

38 questions sourced from real search queries, the revised Schedule M, CDSCO guidance and our experience having assisted 500+ manufacturing compliance files.

Common findings and how they are closed
FindingWhy it is raisedHow it is closed
Batch records completed after the eventContemporaneous recording is an ALCOA+ requirementRetrain, restructure the record, supervise at the point of entry
Shared laboratory loginsRecords must be attributable to an individualUnique user accounts with role-based access
Audit trails never reviewedReview is part of the control, not an optionScheduled audit trail review with recorded outcomes
Qualification records not matching installed equipmentThe file describes a different facilityRequalify and reconcile the asset register
Change control raised after implementationAssessment must precede the changeRework the procedure and evidence prospective approval
Product Quality Review missing or inconclusiveThe revision makes it an express requirementComplete the review with stated conclusions
Self-inspection with no findings ever recordedReads as a formality rather than an auditRun a real internal audit and track findings to closure
Site Master File out of dateInspectors walk the site against itRewrite to the current facility and control revisions

Read down that list and the theme is visible: almost every item is a discipline problem rather than a capability problem. That is good news for cost, because closing them is a matter of procedure, training and supervision rather than capital expenditure. It is bad news for timing, because behaviour takes longer to change than a document does, and an inspector can tell the difference between a procedure issued last week and a practice that has been running for six months.

FAQs

Frequently asked questions about GMP certification vs a private certificate

38 questions sourced from real search queries, the revised Schedule M, CDSCO guidance and our experience having assisted 500+ manufacturing compliance files.

ParameterGMP under Schedule MISO 9001Private GMP certificate
NatureRegulatory requirementVoluntary management system standardVoluntary third-party certification
Who assessesState Licensing Authority with CDSCOAccredited certification bodyThe issuing body
Legal effectCondition of the manufacturing licenceNoneNone
Satisfies Schedule M Yes No No
Accepted by importing regulatorsThrough the WHO-GMP certificate and COPP NoVaries by buyer, rarely by regulator
ScopeThe licensed facility and productsThe organisationAs stated by the issuing body
Typical validityWHO-GMP typically three yearsThree years with surveillance auditsAs stated by the issuing body
Consequence of losing itLicence action and stop-manufacturing riskCertificate withdrawnCertificate withdrawn

Explore: ISO certification, drug and cosmetic licence or CE certification for products entering the European Union.

FAQs

Frequently asked questions about GMP certification

38 questions sourced from real search queries, the revised Schedule M, CDSCO guidance and our experience having assisted 500+ manufacturing compliance files.

Good Manufacturing Practices are the standards a manufacturing facility must meet so that products are consistently produced and controlled to the quality their intended use requires. In India, GMP for drugs is prescribed by Schedule M to the Drugs and Cosmetics Rules, 1945. What is loosely called GMP certification usually means either compliance with Schedule M as a licence condition, or a separate WHO-GMP certificate obtained for export.
Both, depending on which one you mean. Schedule M compliance is a condition of the manufacturing licence granted under the Drugs and Cosmetics Rules, 1945, so a drug maker is required to meet it whether or not any certificate is issued. The WHO-GMP certificate is a separate document, applied for and issued on the strength of an inspection, and it is what overseas buyers and regulators ask to see.
The substantially rewritten version of Schedule M notified on 28 December 2023, which moves Indian GMP requirements much closer to WHO-GMP and EU-GMP expectations. It introduces a formal Pharmaceutical Quality System, Quality Risk Management, an annual Product Quality Review, validation and qualification discipline including computerised systems, and data integrity requirements aligned to ALCOA+ principles.
Manufacturers with turnover above ₹250 crore were given the shorter window from the December 2023 notification. Micro, small and medium manufacturers with turnover up to ₹250 crore were given twelve months, and those who applied within the prescribed window received an extension to 31 December 2025. That extension has expired.
The extension window closed on 31 December 2025 and no further general extension followed. The Central Drugs Standard Control Organisation has directed state drug control authorities to conduct inspections of manufacturing units against the revised requirements. Units that never applied for the extension are inspected without any grace period.
The consequences run through the licence rather than through a certificate. A GMP deficiency found on inspection can lead to a show cause notice, suspension of the product or the section of the licence, a stop-manufacturing direction, or in serious cases cancellation. For an exporter it also closes the WHO-GMP and Certificate of Pharmaceutical Product route until the deficiency is closed.
The ProTax professional fee starts at ₹24,999, and the actual scope drives the number: a gap assessment and documentation build for a single-product oral solid dosage unit is a very different exercise from a sterile facility. Government fees, laboratory testing, validation studies and any facility upgrade are billed at actuals and are usually the larger part of the total.
For a unit with a functioning quality system that needs documentation brought up to the revised Schedule M, typically 8 to 16 weeks. Where premises, HVAC, water systems or equipment need physical upgrading, the timeline is set by the engineering work and commonly runs 6 to 12 months. The WHO-GMP application adds the inspection scheduling on top.

Book your revised Schedule M gap assessment

Talk to an ProTax regulatory compliance expert for a free consultation on where your facility stands, what is documentary and what is structural. From ₹24,999, upgrades at actuals.

FROM THE PROTAX LIBRARY

Recent Articles & Guides

Practical reading on business records, tax filings and the decisions that come with running a company.

Newsletter

Stay ahead on compliance, tax & business updates

Get selected business and compliance updates by email. Once a month, no spam.

  • 100% privacy
  • 1 email / month
  • Unsubscribe anytime
Contact ProTax
Chosen by individuals and businesses

Get Help With Your Business

Tell us what you need help with. Our team will review your enquiry and explain the next steps.

Free Consultation No Obligations Expert Advice
FREE Consultation Get Started @ ₹299 ₹0

Talk To ProTax

Share Your Business Requirement

Instant Response 100% Confidential Expert Advice
FREE Consultation Get Started @ ₹299 ₹0

Request a Free Quote

Share Your Business Requirement

Instant Response 100% Confidential Expert Advice
Get your facility GMP compliant Schedule M gap assessment documentation and inspection readiness Starts at ₹24,999